We are live on ! Find out more
NXTC icon

NextCure
NXTC

43 hedge funds and large institutions have $19.6M invested in NextCure in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $18.4M → $19.6M (+$1.22M)

0.04% less ownership

Funds ownership: 4.02% → 3.98% (-0.04%)

4% less funds holding

Funds holding: 45 → 43 (-2)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
13
Closed
7
Calls
$231K
Puts
–
Net Calls
+$231K
Net Calls Change
+$75K

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$642K
2
BCM
BML Capital Management
Indiana
+$492K
3
Millennium Management
Millennium Management
New York
+$188K
4
Morgan Stanley
Morgan Stanley
New York
+$141K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$93K

Top Sellers

Rank Fund Capital Flow
1
CPA
Cardiff Park Advisors
California
-$369K
2
Goldman Sachs
Goldman Sachs
New York
-$347K
3
Renaissance Technologies
Renaissance Technologies
New York
-$260K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$199K
5
BlackRock
BlackRock
New York
-$196K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$63.7K +$289 +15 +0.4%
ECM
27
ExodusPoint Capital Management
New York
$47K -$5.6K -291 -10%
MA
28
Minerva Advisors
Pennsylvania
$46.9K – – –
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$41.8K -$31.7K -1,645 -41%
Franklin Resources
30
Franklin Resources
California
$36.5K – – –
Fidelity Investments
31
Fidelity Investments
Massachusetts
$29.7K +$8.07K +419 +33%
HSBC Holdings
32
HSBC Holdings
United Kingdom
$25.7K – – –
TRCT
33
Tower Research Capital (TRC)
New York
$21K -$11.3K -586 -33%
UBS Group
34
UBS Group
Switzerland
$18.9K +$3.37K +175 +20%
HP
35
Harbourvest Partners
Massachusetts
$14.9K – – –
Charles Schwab
36
Charles Schwab
California
$14.8K – – –
JP Morgan Chase
37
JP Morgan Chase
New York
$4K – – –
Group One Trading
38
Group One Trading
Illinois
$1.25K +$1.37K +71 New
CG
39
Cutler Group
California
$1K – – –
Northwestern Mutual Wealth Management
40
Northwestern Mutual Wealth Management
Wisconsin
$814 – – –
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$570 -$270 -14 -30%
Wells Fargo
42
Wells Fargo
California
$185 – – –
Bank of America
43
Bank of America
North Carolina
$3 -$77 -4 Closed
CPA
44
Cardiff Park Advisors
California
– -$369K -21,833 Closed
Two Sigma Investments
45
Two Sigma Investments
New York
– -$47.7K -2,821 Closed
Jane Street
46
Jane Street
New York
– -$33.5K -1,979 Closed
VF
47
Virtu Financial
New York
– -$28K -1,632 Closed
E
48
Ergoteles
New York
– -$24.8K -1,465 Closed
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
– -$19.5K -1,155 Closed
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
– +$19 +1 New
1
2

NXTC Hedge Fund Activity: Q1 2023 in Review

43 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q1 2023, worth a combined $19.6M — up 6.6% from $18.4M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NXTC and 5 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 6 added.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $642K. The largest seller was Cardiff Park Advisors, exiting entirely with an estimated $369K sold.

  • 43 institutional investors held NextCure (NXTC) as of Q1 2023, down from 45 in Q4 2022.
  • Funds reported $19.6M of NextCure stock for Q1 2023, up 6.6% quarter-over-quarter.
  • 5 funds opened new NextCure positions in Q1 2023 and 7 closed out, a net change of -2 holders.
  • The largest NextCure buyer in Q1 2023 was Tang Capital Management, an estimated $642K added.
  • The largest NextCure seller in Q1 2023 was Cardiff Park Advisors, an estimated $369K sold.

Based on aggregated 13F filings for Q1 2023.